Managing HIV/AIDS Therapy in Treatment-Experienced Patients Disclosure of Conflicts of Interest Postgraduate Institute for Medicine (PIM) assesses conflict of interest with its instructors, planners, managers and other individuals who are in a position to control the content of CME activities. All relevant conflicts of interest that are identified are thoroughly vetted by PIM for fair balance, scientific objectivity of studies utilized in this activity, and patient care recommendations. PIM is committed to providing its learners with high quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest. The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity: Name of Faculty or Presenter Reported Financial Relationship Nicholaos C. Bellos, MD Research Support: Bristol-Myers Squibb Company; Gilead; GlaxoSmithKline; and Hoffmann-La Roche Inc. Consultant: Bristol-Myers Squibb Company; Gilead; GlaxoSmithKline; and Hoffmann-La Roche Inc. Speakers' Bureaus: Bristol-Myers Squibb Company; Gilead; GlaxoSmithKline; and Hoffmann-La Roche Inc. Helena A. Kwakwa, MD, MPH Consultant: Abbott Laboratories and GlaxoSmithKline. Speakers' Bureaus: Abbott Laboratories; GlaxoSmithKline; Hoffmann-La Roche Inc. Michael Wohlfeiler, MD, JD Disclosed having no relationships with commercial interests related to the content of this activity Planner and Managers Disclosure Trace Hutchison states that he or his spouse/life partner do not have any financial relationship or relationships to products or devices with any commercial interests related to the content of this CME activity of any amount during the last 12 months. Disclosure of Unlabeled Use This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Postgraduate Institute for Medicine (PIM) and GlaxoSmithKline do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of PIM and GlaxoSmithKline. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings. Disclaimer Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patients' conditions and possible contraindications on dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.   Program Menu